For citations:
Malinovskaya E.M., Kozhina E.A., Ershova E.S., Konkova M.S., Veiko V.P., Bobrovsky P.A., Lazarev V.N., Shmarina G.V., Kameneva L.V., Veiko N.N., Kostyuk S.V. Genome editing technology CRISPR/Cas9 in the study of the biological effect of GC-rich cell-free DNA sequences (cfDNA) on the regulation of the transcriptional activity of TLR9 receptor-DNA sensor genes and AIM2 on the MCF7 line cells. Medical Genetics. 2021;20(8):48-59. (In Russ.) https://doi.org/10.25557/2073-7998.2021.08.48-59
Email this article 